338 related articles for article (PubMed ID: 12880487)
1. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
Lee SJ
Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
[TBL] [Abstract][Full Text] [Related]
2. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
3. Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
Rajagopalan S; Andersen JK
Mech Ageing Dev; 2001 Sep; 122(14):1499-510. PubMed ID: 11511392
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
5. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
Hegde ML; Jagannatha Rao KS
Arch Biochem Biophys; 2003 Oct; 418(2):169-78. PubMed ID: 14522588
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic effects of alpha-synuclein aggregation.
Lundvig D; Lindersson E; Jensen PH
Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Rocha EM; De Miranda B; Sanders LH
Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
[TBL] [Abstract][Full Text] [Related]
8. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.
Volles MJ; Lansbury PT
Biochemistry; 2003 Jul; 42(26):7871-8. PubMed ID: 12834338
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein aggregation.
Bodles AM; Irvine GB
Protein Pept Lett; 2004 Jun; 11(3):271-9. PubMed ID: 15182228
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in protein conformational disorders.
Brielle S; Kaganovich D
J Genet; 2018 Jul; 97(3):703-713. PubMed ID: 30027904
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic approaches to Parkinson's disease pathogenesis.
Betarbet R; Sherer TB; Di Monte DA; Greenamyre JT
Brain Pathol; 2002 Oct; 12(4):499-510. PubMed ID: 12408237
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Pozo Devoto VM; Falzone TL
Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
[TBL] [Abstract][Full Text] [Related]
14. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
15. Α-synuclein misfolding and Parkinson's disease.
Breydo L; Wu JW; Uversky VN
Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein oligomerization: a role for lipids?
Welch K; Yuan J
Trends Neurosci; 2003 Oct; 26(10):517-9. PubMed ID: 14522142
[TBL] [Abstract][Full Text] [Related]
18. Function of α-synuclein and PINK1 in Lewy body dementia (Review).
Minami A; Nakanishi A; Matsuda S; Kitagishi Y; Ogura Y
Int J Mol Med; 2015 Jan; 35(1):3-9. PubMed ID: 25355138
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.
Bir A; Sen O; Anand S; Khemka VK; Banerjee P; Cappai R; Sahoo A; Chakrabarti S
J Neurochem; 2014 Dec; 131(6):868-77. PubMed ID: 25319443
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
